Table 2.
O.D. (450 nm) | |||||
---|---|---|---|---|---|
Pathway | Control | PGE2 | PGE3 | 12-S-HEPE | 10-HODE |
AKT1 | 0.18 ± 0.04 | 0.25 ± 0.04 | 0.23 ± 0.03 | 0.19 ± 0.02 | 0.21 ± 0.03 |
AKT2 | 0.17 ± 0.02 | 0.19 ± 0.02 | 0.18 ± 0.03 | 0.21 ± 0.01 | 0.19 ± 0.02 |
P38α | 0.42 ± 0.04 | 0.92 ± 0.04* | 0.99 ± 0.05* | 0.85 ± 0.03* | 0.83 ± 0.04* |
GSKβ | 0.19 ± 0.03 | 0.56 ± 0.08* | 0.52 ± 0.07* | 0.48 ± 0.04* | 0.50 ± 0.06* |
CREB | 0.21 ± 0.02 | 0.82 ± 0.11* | 0.85 ± 0.12* | 0.76 ± 0.13* | 0.69 ± 0.10* |
ERK 1/2 | 0.37 ± 0.03 | 1.06 ± 0.12* | 0.99 ± 0.11* | 0.95 ± 0.14* | 0.89 ± 0.13* |
Caco-2 cells were incubated with PGE2 or PGE3 (10 nM), 12-S-HEPE (100 nM), or 10-HODE (100 nM) for 5 or 15 min, cells were then collected and finally phosphorylated AKT1, AKT2, p38α, GSKβ, CREB, and ERK 1/2 were measured as described in the Material and Methods section and expressed as optical density (450 nm). Data are expressed as means ± SEM of two to four experiments performed in triplicate. *P < 0.05 vs. Caco-2 cell cultures in the absence of FBS.